Antiphospholipid syndrome natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Feham Tariq (talk | contribs) No edit summary Tags: mobile edit mobile web edit |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Antiphospholipid syndrome}} | {{Antiphospholipid syndrome}} | ||
{{CMG}} | {{CMG}}{{AE}}{{FT}} | ||
==Overview== | ==Overview== |
Revision as of 21:39, 30 March 2018
Antiphospholipid syndrome Microchapters |
Differentiating Antiphospholipid syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Antiphospholipid syndrome natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Antiphospholipid syndrome natural history, complications and prognosis |
FDA on Antiphospholipid syndrome natural history, complications and prognosis |
CDC on Antiphospholipid syndrome natural history, complications and prognosis |
Antiphospholipid syndrome natural history, complications and prognosis in the news |
Blogs on Antiphospholipid syndrome natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Feham Tariq, MD [2]